MedPath

Atopix Therapeutics Ltd.

Atopix Therapeutics Ltd. logo
πŸ‡¬πŸ‡§United Kingdom
Ownership
Subsidiary
Established
2012-01-01
Employees
1
Market Cap
-
Website
http://atopixtherapeutics.co.uk

Evaluation of Metabolic Profile of OC000459

Phase 1
Completed
Conditions
Asthma
Interventions
First Posted Date
2015-01-19
Last Posted Date
2015-05-25
Lead Sponsor
Atopix Therapeutics, Ltd.
Target Recruit Count
18
Registration Number
NCT02341521
Locations
πŸ‡¬πŸ‡§

Simbec Research, Merthyr Tydfil, Wales, United Kingdom

First in Man Evaluation of Single and Multiple Doses of Oral ATX2417

Phase 1
Completed
Conditions
Allergy
Interventions
Drug: Placebo
First Posted Date
2014-12-15
Last Posted Date
2016-07-19
Lead Sponsor
Atopix Therapeutics, Ltd.
Target Recruit Count
64
Registration Number
NCT02316912
Locations
πŸ‡¬πŸ‡§

Simbec Research, Merthyr Tydfil, Glamorgan, United Kingdom

Effect of OC000459 on Moderate to Severe Atopic Dermatitis

Phase 2
Completed
Conditions
Atopic Dermatitis
Interventions
First Posted Date
2013-12-05
Last Posted Date
2018-03-26
Lead Sponsor
Atopix Therapeutics, Ltd.
Target Recruit Count
142
Registration Number
NCT02002208
Locations
πŸ‡¬πŸ‡§

University of Sheffield, Sheffield, United Kingdom

Β© Copyright 2025. All Rights Reserved by MedPath